These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28576663)

  • 61. Concomitant Use of Ranolazine and Trimetazidine in Patients with Refractory Angina: An Initial Experience.
    Dourado LOC; Moreno CPD; Grobe SF; Gowdak LHW; Cesar LAM
    Arq Bras Cardiol; 2022 Oct; 119(4):619-621. PubMed ID: 35946755
    [No Abstract]   [Full Text] [Related]  

  • 62. Effects of ranolazine on noninvasive coronary flow reserve in patients with myocardial ischemia but without obstructive coronary artery disease.
    Tagliamonte E; Rigo F; Cirillo T; Astarita C; Quaranta G; Marinelli U; Caruso A; Romano C; Capuano N
    Echocardiography; 2015 Mar; 32(3):516-21. PubMed ID: 25041234
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antinociceptive effect of ranolazine and trimetazidine.
    Tolunay H
    Expert Rev Cardiovasc Ther; 2021 May; 19(5):457-464. PubMed ID: 33823738
    [No Abstract]   [Full Text] [Related]  

  • 64. Improvement of Subjective Well-Being by Ranolazine in Patients with Chronic Angina and Known Myocardial Ischemia (IMWELL Study).
    Bavry AA; Park KE; Choi CY; Mahmoud AN; Wen X; Elgendy IY
    Cardiol Ther; 2017 Jun; 6(1):81-88. PubMed ID: 28044265
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ranolazine reduces repolarization heterogeneity in symptomatic patients with diabetes and non-flow-limiting coronary artery stenosis.
    Evaristo E; Stocco FG; Shah NR; Cheezum MK; Hainer J; Foster C; Nearing BD; Di Carli M; Verrier RL
    Ann Noninvasive Electrocardiol; 2018 Jan; 23(1):. PubMed ID: 28653394
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial.
    Birkeland K; Khandwalla RM; Kedan I; Shufelt CL; Mehta PK; Minissian MB; Wei J; Handberg EM; Thomson LE; Berman DS; Petersen JW; Anderson RD; Cook-Wiens G; Pepine CJ; Bairey Merz CN
    JMIR Res Protoc; 2017 Dec; 6(12):e255. PubMed ID: 29263019
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impact of ranolazine on clinical outcomes and healthcare resource utilization in patients with refractory angina pectoris.
    Ling H; Packard KA; Burns TL; Hilleman DE
    Am J Cardiovasc Drugs; 2013 Dec; 13(6):407-12. PubMed ID: 23873327
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The use of ranolazine in non-anginal cardiovascular disorders: A review of current data and ongoing randomized clinical trials.
    Mihos CG; Krishna RK; Kherada N; Larrauri-Reyes M; Tolentino A; Santana O
    Pharmacol Res; 2016 Jan; 103():49-55. PubMed ID: 26546970
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Old and New Drugs for Treatment of Stable Angina: New Anti-Anginal Drugs and Coronary Revascularization.
    Secco GG; Parisi R; Mirabella F; Rognoni A; Lupi A; De Luca G; Marino PN; Fattori R; Cremonesi A; Castriota F
    Cardiovasc Hematol Agents Med Chem; 2015; 13(1):21-4. PubMed ID: 25544117
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Percutaneous coronary intervention for poor coronary microcirculation reperfusion of patients with stable angina pectoris.
    Li JS; Zhao XJ; Ma BX; Wang Z
    J Biol Regul Homeost Agents; 2016; 30(3):733-741. PubMed ID: 27655490
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impact of angina frequency on health utility values of patients with chronic stable angina.
    Kohn CG; Parker MW; Limone BL; Coleman CI
    Health Qual Life Outcomes; 2014 Mar; 12():39. PubMed ID: 24628859
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effect of Shexiang Tongxin Dropping Pills on coronary microvascular dysfunction (CMVD) among those with a mental disorder and non-obstructive coronary artery disease based on stress cardiac magnetic resonance images: A study protocol.
    Tian J; Zhang L; Yang X; Zuo H; Zhao X; Yong J; He Y; Song X
    Medicine (Baltimore); 2020 May; 99(21):e20099. PubMed ID: 32481277
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Quantitative assessment of coronary microvascular function in patients with and without epicardial atherosclerosis.
    Melikian N; Vercauteren S; Fearon WF; Cuisset T; MacCarthy PA; Davidavicius G; Aarnoudse W; Bartunek J; Vanderheyden M; Wyffels E; Wijns W; Heyndrickx GR; Pijls NH; de Bruyne B
    EuroIntervention; 2010 Apr; 5(8):939-45. PubMed ID: 20542779
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of the Seattle Angina Questionnaire With Daily Angina Diary in the TERISA Clinical Trial.
    Arnold SV; Kosiborod M; Li Y; Jones PG; Yue P; Belardinelli L; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):844-50. PubMed ID: 25249560
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study.
    Oh PC; Kang WC; Moon J; Park YM; Kim S; Kim MG; Lee K; Ahn T; Shin EK
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):221-8. PubMed ID: 27021556
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A clinical trial for computed tomography myocardial perfusion based non-invasive index of microcirculatory resistance (MPBIMR): rationale and trial design.
    Gao B; Zhu D; Xie J; Wu B; Xu P; Liu J; Tong X; Chen R; Zhu L; Zhou L; Qian Y; Ye X; Yang J; Meng S; Gu J; Tong G; Huang J
    Am J Transl Res; 2022; 14(8):5552-5562. PubMed ID: 36105013
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
    Morrow DA; Scirica BM; Karwatowska-Prokopczuk E; Murphy SA; Budaj A; Varshavsky S; Wolff AA; Skene A; McCabe CH; Braunwald E;
    JAMA; 2007 Apr; 297(16):1775-83. PubMed ID: 17456819
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Direct stenting for stable angina pectoris is associated with reduced periprocedural microcirculatory injury compared with stenting after pre-dilation.
    Cuisset T; Hamilos M; Melikian N; Wyffels E; Sarma J; Sarno G; Barbato E; Bartunek J; Wijns W; De Bruyne B
    J Am Coll Cardiol; 2008 Mar; 51(11):1060-5. PubMed ID: 18342222
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The index of microvascular resistance identifies patients with periprocedural myocardial infarction in elective percutaneous coronary intervention.
    Layland JJ; Whitbourn RJ; Burns AT; Somaratne J; Leitl G; Macisaac AI; Wilson A
    Heart; 2012 Oct; 98(20):1492-7. PubMed ID: 22895644
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials.
    Wenger NK; Chaitman B; Vetrovec GW
    Am J Cardiol; 2007 Jan; 99(1):11-8. PubMed ID: 17196454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.